Amylyx Pharmaceuticals, Inc. (AMLX) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$153.29M | +51.3% |
| 2024 | -$314.73M | -911.1% |
| 2023 | $38.80M | +119.3% |
| 2022 | -$201.34M | -143.5% |
| 2021 | -$82.69M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$153.29M | +51.3% |
| 2024 | -$314.73M | -911.1% |
| 2023 | $38.80M | +119.3% |
| 2022 | -$201.34M | -143.5% |
| 2021 | -$82.69M | — |